Cellular Dynamics - Top 15 Biotech VC Deals of 2010

Company: Cellular Dynamics International
Based: Madison, WI
Amount: $40.6M

Investors: Tactics II Stem Cell Ventures, Sam Zell's Equity Group Investments and Sixth Floor Investors

Scoop: A 2008 Fierce 15 member, Cellular Dynamics added $40.6 million in Series B financing to grow its stem cell production. The company is the world's highest volume manufacturer of human heart cells and plans to use the added funds to enter other markets.

Cellular Dynamics - Top 15 Biotech VC Deals of 2010
Read more on

Suggested Articles

Trials for cancer drugs undertaken in Europe in the mid-2010s were flawed to such a degree as to “raise questions” over their true benefits to patients.

Combining inhibitors of KRAS-G12C, mTOR and IGF1R can significantly shrink lung tumors in mice and human cancer cells, a study found.

X4 Pharmaceuticals has a new R&D chief: Renato Skerlj, who founded the company alongside CEO Paula Ragan and biotech luminary Henri Termeer.